158 related articles for article (PubMed ID: 8108420)
1. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice.
Crowe JE; Murphy BR; Chanock RM; Williamson RA; Barbas CF; Burton DR
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1386-90. PubMed ID: 8108420
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
[TBL] [Abstract][Full Text] [Related]
3. Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases.
Chanock RM; Crowe JE; Murphy BR; Burton DR
Infect Agents Dis; 1993 Jun; 2(3):118-31. PubMed ID: 8173784
[TBL] [Abstract][Full Text] [Related]
4. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
Graham BS; Davis TH; Tang YW; Gruber WC
Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.
Haynes LM; Tonkin J; Anderson LJ; Tripp RA
J Virol; 2002 Jul; 76(14):6873-81. PubMed ID: 12072488
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
[TBL] [Abstract][Full Text] [Related]
7. A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.
Boyoglu-Barnum S; Gaston KA; Todd SO; Boyoglu C; Chirkova T; Barnum TR; Jorquera P; Haynes LM; Tripp RA; Moore ML; Anderson LJ
J Virol; 2013 Oct; 87(20):10955-67. PubMed ID: 23885067
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of immunity induced by viral antigen or conferred by antibody via different administration routes.
Matsuoka T; Okamoto Y; Matsuzaki Z; Endo S; Ito E; Tsutsumi H; Williamson RA; Sakurai H; Burton DR; Saito I
Clin Exp Immunol; 2002 Dec; 130(3):386-92. PubMed ID: 12452827
[TBL] [Abstract][Full Text] [Related]
9. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection.
Weltzin R; Traina-Dorge V; Soike K; Zhang JY; Mack P; Soman G; Drabik G; Monath TP
J Infect Dis; 1996 Aug; 174(2):256-61. PubMed ID: 8699052
[TBL] [Abstract][Full Text] [Related]
10. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
11. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity.
Barbas CF; Crowe JE; Cababa D; Jones TM; Zebedee SL; Murphy BR; Chanock RM; Burton DR
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10164-8. PubMed ID: 1279672
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
Haynes LM; Caidi H; Radu GU; Miao C; Harcourt JL; Tripp RA; Anderson LJ
J Infect Dis; 2009 Aug; 200(3):439-47. PubMed ID: 19545210
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
15. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.
Williams JV; Chen Z; Cseke G; Wright DW; Keefer CJ; Tollefson SJ; Hessell A; Podsiad A; Shepherd BE; Sanna PP; Burton DR; Crowe JE; Williamson RA
J Virol; 2007 Aug; 81(15):8315-24. PubMed ID: 17522220
[TBL] [Abstract][Full Text] [Related]
16. Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus.
Thomas LH; Cook RS; Wyld SG; Furze JM; Taylor G
J Infect Dis; 1998 Apr; 177(4):874-80. PubMed ID: 9534958
[TBL] [Abstract][Full Text] [Related]
17. An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.
Boyoglu-Barnum S; Todd SO; Chirkova T; Barnum TR; Gaston KA; Haynes LM; Tripp RA; Moore ML; Anderson LJ
Virology; 2015 Sep; 483():117-25. PubMed ID: 25965801
[TBL] [Abstract][Full Text] [Related]
18. Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.
Weltzin R; Hsu SA; Mittler ES; Georgakopoulos K; Monath TP
Antimicrob Agents Chemother; 1994 Dec; 38(12):2785-91. PubMed ID: 7695263
[TBL] [Abstract][Full Text] [Related]
19. Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice.
Miao C; Radu GU; Caidi H; Tripp RA; Anderson LJ; Haynes LM
J Gen Virol; 2009 May; 90(Pt 5):1119-1123. PubMed ID: 19264600
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.
Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB
Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
